These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 3380877
1. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154. Al-Wathiqui MH, Shimshak TM, Brooks HL, Preuss KC, Wynsen JC, Gross GJ, Warltier DC. Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877 [Abstract] [Full Text] [Related]
2. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Pagel PS, Harkin CP, Hettrick DA, Warltier DC. Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849 [Abstract] [Full Text] [Related]
3. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. Harkin CP, Pagel PS, Tessmer JP, Warltier DC. J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041 [Abstract] [Full Text] [Related]
4. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. Pagel PS, Harkin CP, Hettrick DA, Warltier DC. J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540 [Abstract] [Full Text] [Related]
5. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs. Gosgnach M, Gérard JL, Berdeaux A, Giudicelli JF. Fundam Clin Pharmacol; 1991 Oct; 5(8):709-18. PubMed ID: 1783360 [Abstract] [Full Text] [Related]
6. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs. Lee KC, Clas DM, Gorczyca WP, Silver PJ, Ezrin AM. Drugs Exp Clin Res; 1991 Oct; 17(7):323-36. PubMed ID: 1686584 [Abstract] [Full Text] [Related]
7. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs. Pagel PS, Hettrick DA, Warltier DC. Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755 [Abstract] [Full Text] [Related]
8. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Pagel PS, Hettrick DA, Warltier DC. Basic Res Cardiol; 1996 Oct; 91(4):296-307. PubMed ID: 8874779 [Abstract] [Full Text] [Related]
9. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E. Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [Abstract] [Full Text] [Related]
10. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [Abstract] [Full Text] [Related]
11. Direct negative inotropic and lusitropic effects of sevoflurane. Harkin CP, Pagel PS, Kersten JR, Hettrick DA, Warltier DC. Anesthesiology; 1994 Jul; 81(1):156-67. PubMed ID: 8042785 [Abstract] [Full Text] [Related]
12. Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog. Gerard JL, Berdeaux A, Giudicelli JF. Eur J Pharmacol; 1989 Jun 08; 165(1):39-49. PubMed ID: 2767134 [Abstract] [Full Text] [Related]
13. Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent. Abe Y, Kitada Y, Narimatsu A, Tobe A. Eur J Pharmacol; 1991 Jan 10; 192(2):279-85. PubMed ID: 2032560 [Abstract] [Full Text] [Related]
14. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM. Am J Physiol Heart Circ Physiol; 2008 Jan 10; 294(1):H238-48. PubMed ID: 17982006 [Abstract] [Full Text] [Related]
15. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine. Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB. J Cardiovasc Pharmacol; 1987 Nov 10; 10(5):509-16. PubMed ID: 2447398 [Abstract] [Full Text] [Related]
16. Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: comparison with dobutamine and milrinone. Sato N, Uechi M, Asai K, Patrick T, Kudej RK, Vatner SF. Am J Physiol; 1997 Feb 10; 272(2 Pt 2):H753-9. PubMed ID: 9124435 [Abstract] [Full Text] [Related]
17. The interaction of MCI-154, a calcium sensitizer, and isoflurane on systemic and coronary hemodynamics in chronically instrumented dogs. Takahashi S, Cho S, Hara T, Ureshino H, Tomiyasu S, Sumikawa K. Anesth Analg; 2004 Jan 10; 98(1):30-36. PubMed ID: 14693578 [Abstract] [Full Text] [Related]
18. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure. Sonnenblick EH, Grose R, Strain J, Zelcer AA, LeJemtel TH. Circulation; 1986 Mar 10; 73(3 Pt 2):III162-7. PubMed ID: 3510772 [Abstract] [Full Text] [Related]
19. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS. Circulation; 1986 Jan 10; 73(1):130-7. PubMed ID: 3940664 [Abstract] [Full Text] [Related]
20. Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan. Abe Y, Kitada Y, Narimatsu A. J Pharmacol Exp Ther; 1992 Jun 10; 261(3):1087-95. PubMed ID: 1602375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]